Skip to main content
2024 Guide to Patient Support Services

Coherus BioSciences

2024 PSS Guide

Coherus Solutions

Coherus BioSciences’ Coherus Solutions offers comprehensive reimbursement and support services for patients receiving treatment with Udenyca (pegfilgrastim-cbqv) who are unable to afford this medication. The program also offers provider coding and billing services to facilitate appropriate billing and reimbursement.

Coherus Solutions

Coherus Solutions provides several financial assistance options for patients who have been prescribed Udenyca.

Co-Pay Assistance Program

This program covers out-of-pocket costs for eligible, commercially insured patients.

Patient Assistance Program

Udenyca may be provided to eligible uninsured and underinsured patients.

Provider Portal and Payer Coverage Tool

Provider support services are available through the Provider Portal as well as through the Payer Coverage Tool, which together facilitate access to reimbursement specialists and information about state-specific treatment coverage. Reimbursement support services include:

  • Assistance with the verification of insurance and benefits details
  • Udenyca-specific coding, billing details, and claims appeal process
  • Prior authorization requirements and facilitation.

Application and Enrollment

For information on enrollment in Coherus Solutions, call 844-483-3692 or visit the Coherus Solutions Provider Portal.

TABLE Coherus BioSciences Oncology Drug

Patient support programs

Udenyca (pegfilgrastim-cbqv)
Indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anticancer drugs associated with a clinically significant incidence of febrile neutropenia; indicated to increase survival in patients acutely exposed to myelosuppressive doses of radiation (hematopoietic subsyndrome of acute radiation syndrome)
Patient support programs